期刊文献+

血液输注与脱离输血依赖在异基因造血干细胞移植中的研究 被引量:2

暂未订购
导出
摘要 目的评价接受异基因造血干细胞移植(allo-HSCT)患者移植期间红细胞(RBC)和血小板(Plt)输注需求的影响因素。方法回顾性分析接受allo-HSCT患者的血液制品使用情况。结果 79.7%的患者在移植后6个月内脱离了输血依赖。无关供者组脱离输注时间明显延长(P<0.05),HLA不全相合组脱离输注时间亦明显延长(P<0.05)。与淋巴瘤和骨髓增生异常综合征患者比较,白血病患者移植后脱离输注时间明显缩短。与相关供者组比较,移植后60 d无关供者组需要更多的Plt输注(P<0.05)。结论尽管移植后中性粒细胞快速植入,但无关供者组Plt恢复时间明显延迟。如何降低无关供者和HLA配型不合供者为来源的移植输血成本值得进一步探讨。
出处 《广东医学》 CAS CSCD 北大核心 2012年第3期344-346,共3页 Guangdong Medical Journal
  • 相关文献

参考文献10

  • 1GANGULY S,BRADLEY J P,PATEL J S,et al.Role of transfu-sion in stem cell transplantation:a freedom-from-transfusion(FFT),cost and survival analysis[J].J Med Econ,2010,13(1):55-62.
  • 2宋奎,邱大发,郭子文,何慧清,简黎,黄贵年,黄桂英,刘安棃,许晓军.输血支持在造血干细胞移植中的应用[J].中国组织工程研究与临床康复,2011,15(19):3513-3517. 被引量:8
  • 3NEVO S,FULLER A K,HARTLEY E,et al.Acute bleedingcomplications in patients after hematopoietic stem cell transplanta-tion with prophylactic platelet transfusion triggers of 10×10(9)and 20×10(9)per L[J].Transfusion,2007,47(5):801-812.
  • 4NEVO S,VOGELSANG G B.Acute bleeding complications in pa-tients after bone marrow transplantation[J].Curr Opin Hematol,2001,8(5):319-325.
  • 5Amihud, Yakov, and Haim Mendelson. Asset pricing and the bid-ask spread [J]. Journal of Financial Economics,1986,17,223-249.
  • 6Fiori, Filippo. Liquidity premia in the equity markers: An investigation into the characteristics of liquidity and trading activity[R]. Working paper, University of Chicago, 2001.
  • 7Amihud. Illiquidity and stock returns: cross-section and time-series effects[J]. Journal of Financial Markets,2002,5:55-79.
  • 8Jones Charles. A century of stock market liquidity and trading costs[R]. Working paper, Columbia University, 2001.
  • 9Vayanos, Dinitri. Transaction costs and asset prices: A dynamic equilibrium model[J].Review of Financial Studies,1998,11:1-58.
  • 10Grossman Sanford, Merton Miller. Liquidity and market structure[J]. Journal of Finance,1988,43:617-637.

二级参考文献20

  • 1Ganguly S,Bradley JP,Patel JS,et al.Role of transfusion in stem cell transplantation:a freedom-from-transfusion (FFT),cost and survival analysis.J Med Econ.2010;13(1):55-62.
  • 2Worel N,Panzer S,Reesink HW,et al.Transfusion policy in ABO-incompatible allogeneic stem cell transplantation.Vox Sang.2010;98(3 Pt 2):455-467.
  • 3Dahl D,Hahn A,Koenecke C,et al.Prolonged isolated red blood cell transfusion requirement after allogeneic blood stem cell transplantation:identification of patients at risk.Transfusion.2010; 50(3):649-655.
  • 4Prébet T,Ladaique P,Ferrando M,et al.Platelet recovery and transfusion needs after reduced intensity conditioning allogeneic peripheral blood stem cell transplantation.Exp Hematol.2010; 38(1):55-60.
  • 5Curcioli AC,de Carvalho EC.Infusion of hematopoietic stem cells:types,characteristics,adverse and transfusion reactions and the implications for nursing.Rev Lat Am Enfermagem.2010;18(4):716-724.
  • 6Marktel S,Napolitano S,Zino E,et al.Platelet transfusion refractoriness in highly immunized beta thalassemia children undergoing stem cell transplantation.Pediatr Transplant.2010; 14(3):393-401.
  • 7Alessandrino EP,Della Porta MG,Bacigalupo A,et al.Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation:a GITMO study.Haematologica.2010;95(3):476-484.
  • 8Kim YR,Kim JS,Cheong JW,et al.Transfusion-associated iron overload as an adverse risk factor for transplantation outcome in patients undergoing reduced-intensity stem cell transplantation for myeloid malignancies.Acta Haematol.2008;120(3):182-189.
  • 9Citak EC,Kesik V,Atay AA,et al.Transfusion-related acute lung injury in a child with neuroblastoma during a late engraftment period of autologous stem cell transplantation.Pediatr Transplant.2008;12(2):235-237.
  • 10Corash L,Lin JS,Sherman CD,et al.Determination of acute lung injury after repeated platelet transfusions.Blood.2011;117(3):1014-1020.

共引文献8

同被引文献17

  • 1ZHANG X, XIAO Y, RAN Q, et al. Clinical observation of fac- tors in the efficacy of blood component transfusion in patients fol- lowing hematopoietic stem cell transplantation [ J ]. PLoS One, 2012, 7(5) : e36912.
  • 2LEAL NOVAL S R, ARELLANO ORDEN V, MAESTRE ROME- RO A, et al. Impact of national transfusion indicators on appropri- ate blood usage in critically ill patients [J]. Transfusion, 2011,51 (9) : 1957 -1965.
  • 3CRUDELE V, PICASCIA A, INFANTE T, et al. Repeated im- mune and non immune insults to the graft after heart transplantation [J]. ImmunolLett, 2011, 141(1): 18 -27.
  • 4HATAKEYAMA N, HORI T, YAMAMOTO M, et al. Platelet transfusion refractoriness attributable to HLA antibodies produced by donor - derived cells after allogeneic bone marrow transplanta- tion from one HLA - antigen - mismatched mother [J].Pediatr Transplant, 2011, 15(8) : E177 - E182.
  • 5AUNG F M, LICHTIGER B, BASSETT R, et al. Incidence and natural history of pure red cell aplasia in major ABO - mismatched haematopoietic cell transplantation[J]. BrJ Haematol, 2013, 160 (6) : 798 -805.
  • 6MARKTEL S, NAPOLITANO S, ZINO E, et al. Platelet transfu- sion refractoriness in highly immunized beta thalassemia children undergoing stem cell transplantatiotl[J]. Pediatr Transplant, 2010, 14(3) : 393 -401.
  • 7STERN M, INFANTI L, O'MEARA A, et al. Role of donor and recipient sex in platelet transfusion [J].Transfusion, 2013, 53 (11): 2801 -2806.
  • 8MAJHAIL N S, MOTHUKURI J M, BRUNSTEIN C G, et al. Costs of hematopoietic cell transplantation : comparison of umbilical cord blood and matched related donor transplantation and the im- pact of posttransplant complications [ J ]. Biol Blood Marrow Trans- plant, 2009, 15(5): 564-573.
  • 9宋奎,邱大发,郭子文,何慧清,简黎,黄贵年,黄桂英,刘安棃,许晓军.输血支持在造血干细胞移植中的应用[J].中国组织工程研究与临床康复,2011,15(19):3513-3517. 被引量:8
  • 10宋奎,郭子文,何慧清,简黎,邱大发,黄贵年,林淑华,任志娟,黎伟超,刘安棃,许晓军.造血干细胞移植与血小板输注[J].中国组织工程研究与临床康复,2011,15(14):2567-2571. 被引量:4

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部